Abstract
This Note of Concern relates to Al-Gayyar et al Am J Pathol 177:1187–1197 and Correction 185:1795–1796.
It has been brought to our attention that “Neurovascular Protective Effect of FeTPPs in N-Methyl-d-Aspartate Model: Similarities to Diabetes,” by Mohammed M.H. Al-Gayyar, Mohammed A. Abdelsaid, Suraporn Matragoon, Bindu A. Pillai, and Azza B. El-Remessy (Volume 177, Issue 3, pages 1187–1197 of the September 2010 issue of The American Journal of Pathology; http://dx.doi.org/10.2353/ajpath.2010.091289) contained fabricated data in the original Figures 1C, 2A, and 4D. Corrections (to replace duplicated images) were published in the June 2015 issue (Volume 185, Issue 6, pages 1795–1796; http://dx.doi.org/10.1016/j.ajpath.2015.02.022).
This matter was brought to the attention of the Editors by the University of Georgia, who have taken the lead role in investigating allegations of research misconduct against Dr. Azza El-Remessy, Associate Professor in the University of Georgia College of Pharmacy. The inquiry also involved Augusta University (formerly Georgia Regents University) and the Charlie Norwood Veterans Affairs Medical Center where Dr. El-Remessy has additional appointments. The Vice President for Research and the Investigation Committee concluded that Dr. El-Remessy committed research misconduct by falsification or fabrication in specific figures.
The Editors of the Journal are hereby publicly notifying readers of the concerns surrounding the data and their previously published corrections.